Risk factor
Very poor trading liquidity
Profitability factor
Very weak growth
About
Valiant Laboratories Limited, an India-based manufacturer, specializes in active pharmaceutical ingredients (APIs) and bulk drugs, supplying its products to both domestic and international markets. A core offering is paracetamol, which it manufactures adhering to various pharmacopeial standards, including Indian, British, European, and United States specifications. This versatile compound is utilized for alleviating a variety of ailments such as headaches, muscle discomfort, arthritis, backaches, toothaches, colds, and fevers. Additionally, the company provides specialty chemicals. Established in Mumbai in 1980, the firm was previously known as Bharat Chemicals until its rebranding as Valiant Laboratories Limited in August 2021. It operates as a subsidiary under the umbrella of Dhanvallabh Ventures LLP.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.